HIV Provider Intervention to Address Intersectional Stigma and Medical Mistrust
Launched by RAND · Mar 25, 2023
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is focused on improving how healthcare providers address important issues like stigma and mistrust in medical settings among Black and Latina/Latino Americans living with HIV. These issues can lead to significant health disparities, and the trial aims to create an online training program for HIV care providers. This program will help them learn skills to better support their patients and build trust, making the healthcare experience more positive and effective.
To participate in this trial, healthcare providers such as doctors, nurse practitioners, and case managers must care for patients living with HIV, primarily from racial or ethnic minority backgrounds. They also need to be able to commit time to the study. Participants will take part in a pilot study where they will either receive the online training or be in a control group that does not receive the training. The researchers will then evaluate how well the training works over time. This study is currently active but not recruiting new participants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • clinical providers (including physicians, physician assistants, nurse practitioners, registered nurses/case managers) caring for patients living with HIV,
- • the majority of their patients are from racial/ethnic and sexual minority groups,
- • can make the time commitment to participate in the study.
- Exclusion Criteria:
- • not HIV clinical providers
- • cannot make the time commitment to participate
About Rand
RAND is a leading nonprofit research organization dedicated to improving policy and decision-making through rigorous analysis and evidence-based solutions. With a commitment to advancing public health, RAND conducts innovative clinical trials that aim to evaluate new treatments, interventions, and health policies. By leveraging multidisciplinary expertise and a collaborative approach, RAND strives to translate research findings into actionable insights that enhance healthcare outcomes and inform stakeholders across the medical and policy landscapes. Through its comprehensive studies, RAND plays a pivotal role in shaping the future of health and wellness on a global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Santa Monica, California, United States
Patients applied
Trial Officials
Lu Dong, PhD
Principal Investigator
RAND
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials